Tocilizumab, ipilimumab, and nivolumab for the treatment of advanced melanoma, non-small cell lung cancer, or urothelial carcinoma

被引：2
|
作者：
Diab, A. [1 ]
Abdel-Wahab, N. [2 ,3 ]
Bentebibel, S. E. [1 ]
Montazari, E. J. [1 ]
Spillson, C. A. [1 ]
Ekmekcioglu, S. [1 ]
Gao, J. [4 ]
Altan, M. [5 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Melanoma Med Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Gen Internal Med Melanoma Med Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Melanoma Med Oncol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Genitourinary Med Oncol, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.10.188
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
169TiP
引用
收藏
页码：S1456 / S1456
页数：1
相关论文
共 50 条
  • [1] The safety of nivolumab for the treatment of advanced non-small cell lung cancer
    Metro, Giulio
    Ricciuti, Biagio
    Brambilla, Marta
    Baglivo, Sara
    Soli, Irene
    Minenza, Elisa
    Leonardi, Giulia Costanza
    D'arpino, Alessandro
    Colabrese, Daniela
    Tazza, Marco
    Zicari, Daniela
    Minotti, Vincenzo
    Chiari, Rita
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (01) : 101 - 109
  • [2] Clinical outcome of nivolumab and ipilimumab in untreated advanced non-small cell lung cancer patients
    Sugimoto, Akira
    Kaneda, Hiroyasu
    Nagamine, Hiroaki
    Nakahama, Kenji
    Ogawa, Koichi
    Matsumoto, Yoshiya
    Sawa, Kenji
    Tani, Yoko
    Mitsuoka, Shigeki
    Kimura, Tatsuo
    Kawaguchi, Tomoya
    ANNALS OF ONCOLOGY, 2023, 34 : S1451 - S1451
  • [3] Cost-effectiveness of Nivolumab-Ipilimumab Combination Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer
    Courtney, P. Travis
    Yip, Anthony T.
    Cherry, Daniel R.
    Salans, Mia A.
    Kumar, Abhishek
    Murphy, James D.
    JAMA NETWORK OPEN, 2021, 4 (05)
  • [4] Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer
    Hellmann, M. D.
    Paz-Ares, L.
    Bernabe Caro, R.
    Zurawski, B.
    Kim, S. -W.
    Carcereny Costa, E.
    Park, K.
    Alexandru, A.
    Lupinacci, L.
    de la Mora Jimenez, E.
    Sakai, H.
    Albert, I.
    Vergnenegre, A.
    Peters, S.
    Syrigos, K.
    Barlesi, F.
    Reck, M.
    Borghaei, H.
    Brahmer, J. R.
    O'Byrne, K. J.
    Geese, W. J.
    Bhagavatheeswaran, P.
    Rabindran, S. K.
    Kasinathan, R. S.
    Nathan, F. E.
    Ramalingam, S. S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21): : 2020 - 2031
  • [5] Phase I Study of Nivolumab and Ipilimumab Combined with Nintedanib in Advanced Non-Small Cell Lung Cancer
    Puri, S.
    Guadalupe, N. Rodriguez
    Niyongere, S.
    Boyle, T.
    Thapa, R.
    Chen, D.
    Noyes, D.
    Chatwal, M.
    Antonia, S.
    Gray, J. E.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S640 - S641
  • [6] The Impact of Gut Microbiome on the Efficacy of Ipilimumab plus Nivolumab in Advanced Non-Small Cell Lung Cancer
    Katayama, Yuki
    Yamada, Tadaaki
    Sawada, Ryo
    Harada, Taishi
    Chihara, Yusuke
    Yoshimura, Akihiro
    Shiotsu, Shinsuke
    Okada, Asuka
    Yamada, Takahiro
    Takemura, Yoshizumi
    Takayama, Koichi
    CANCER SCIENCE, 2025, 116 : 527 - 527
  • [7] Thyroid storm induced by combined nivolumab and ipilimumab immunotherapy in advanced non-small cell lung cancer
    Kataoka, Shunichi
    Matsuno, Kei
    Sugano, Koji
    Takahashi, Kazuhisa
    BMJ CASE REPORTS, 2022, 15 (10)
  • [8] Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
    Reuss, Joshua E.
    Anagnostou, Valsamo
    Cottrell, Tricia R.
    Smith, Kellie N.
    Verde, Franco
    Zahurak, Marianna
    Lanis, Mara
    Murray, Joseph C.
    Chan, Hok Yee
    McCarthy, Caroline
    Wang, Daphne
    White, James R.
    Yang, Stephen
    Battafarano, Richard
    Broderick, Stephen
    Bush, Errol
    Brock, Malcolm
    Ha, Jinny
    Jones, David
    Merghoub, Taha
    Taube, Janis
    Velculescu, Victor E.
    Rosner, Gary
    Illei, Peter
    Pardoll, Drew M.
    Topalian, Suzanne
    Naidoo, Jarushka
    Levy, Ben
    Hellmann, Matthew
    Brahmer, Julie R.
    Chaft, Jamie E.
    Forde, Patrick M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [9] Nivolumab plus ipilimumab as first-line treatment for patients with advanced non-small cell lung cancer: A systematic review
    Tandiono, J.
    Chen, S.
    Marcella, E.
    Susanto, B.
    Heriyanto, R. S.
    Wijovi, F.
    Tancherla, A.
    Kurniawan, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S759 - S760
  • [10] Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancer
    Tanaka, Kentaro
    Chamoto, Kenji
    Saeki, Sho
    Hatae, Ryusuke
    Ikematsu, Yuki
    Sakai, Kazuko
    Ando, Nobuhisa
    Sonomura, Kazuhiro
    Kojima, Shinsuke
    Taketsuna, Masanori
    Kim, Young Hak
    Yoshida, Hironori
    Ozasa, Hiroaki
    Sakamori, Yuichi
    Hirano, Tomoko
    Matsuda, Fumihiko
    Hirai, Toyohiro
    Nishio, Kazuto
    Sakagami, Takuro
    Fukushima, Masanori
    Nakanishi, Yoichi
    Honjo, Tasuku
    Okamoto, Isamu
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (675)
12345